UNITED ARAB EMIRATES CARDIOVASCULAR ULTRASOUND MARKET FORECAST 2026-2034

Health technology, AI-driven diagnostics, and smart hospital infrastructure are central to this vision. At Arab Health 2024, the UAE Ministry of Health and Prevention reaffirmed its commitment to building a comprehensive preventive health system aligned with AI-driven population health initiatives, a policy direction that directly supports procurement of advanced cardiac imaging systems.

Private hospital expansion is adding further momentum. Burjeel Holdings opened nine new primary care clinics in late 2024 as part of an AED 20 million investment. NMC Healthcare, serving 5-6 million patients annually through 85 facilities, is expanding with nine additional hospitals and clinics. These expansions are broadening the institutional base for cardiovascular ultrasound procurement across both Abu Dhabi and Dubai, and increasingly into the Northern Emirates.

The UAE also benefits from a thriving medical tourism ecosystem. International patients seek out UAE hospitals, particularly institutions like the Cleveland Clinic Abu Dhabi and Sheikh Shakhbout Medical City, for advanced cardiac care. This drives demand for premium-tier cardiac ultrasound systems that meet international clinical standards.

Together, a high-income patient base, strong government policy tailwinds, rapid private hospital growth, and a distinctly technology-forward procurement culture make the UAE one of the most commercially attractive cardiovascular imaging markets in the broader Middle East and Africa region.

The United Arab Emirates cardiovascular ultrasound market is segmented by device display, technology, application, type, and end-user. The technology segment is further categorized into 2D ultrasound, 3D & 4D ultrasound, and Doppler imaging.

The 3D & 4D ultrasound sub-segment holds a dominant and fast-growing share within the technology segment of the UAE cardiovascular ultrasound market. This reflects the country’s distinctly premium procurement profile. The UAE is home to some of the most advanced cardiac centers in the Middle East. These institutions, including major tertiary hospitals in Abu Dhabi and Dubai, operate at international standards and consistently procure the latest imaging platforms available globally.

3D and 4D echocardiography offers capabilities that 2D platforms cannot match. It provides volumetric cardiac imaging that enables precise assessment of valvular anatomy, three-dimensional chamber quantification, and real-time guidance for structural heart interventions. These capabilities are highly relevant in the UAE, where complex cardiac procedures are performed routinely at flagship institutions and where clinical staff are trained to leverage the full depth of advanced echocardiographic technologies.

Moreover, the UAE’s growing focus on AI-enhanced diagnostics, underpinned by the national AI strategy and the “We the UAE 2031” vision, is accelerating adoption of next-generation 3D and 4D platforms that embed automated measurements and AI-assisted workflow tools. For vendors in the cardiovascular imaging market, the 3D & 4D ultrasound sub-segment represents both a premium revenue opportunity and a key differentiation battleground in the UAE, where technology leadership and clinical credibility are decisive procurement criteria.

Some of the top players operating in the UAE cardiovascular ultrasound market include Siemens Healthineers AG, GE HealthCare, Koninklijke Philips NV, Canon Medical Systems Corporation, Esaote SpA, etc.

Siemens Healthineers AG is an Erlangen, Germany-headquartered global medical technology company and one of the most strategically active players in the UAE cardiovascular ultrasound market. The company operates across diagnostic imaging, laboratory diagnostics, and cancer care, with cardiovascular ultrasound forming a core component of its imaging portfolio.

Siemens Healthineers has a direct presence in the Middle East and Africa, led by its regional managing director Vivek Kanade, and consistently uses Arab Health, the region’s flagship medical technology exhibition, held in Dubai, as a primary market engagement and product launch platform. In fiscal year 2024, Siemens Healthineers generated approximately €22.4 billion in revenue globally, a scale that supports sustained R&D, regional service infrastructure, and long-term commercial commitment to the UAE cardiovascular ultrasound market.